Trial
NCT02050009
Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Fox Chase Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
Ovarian Papillary Serous Carcinoma
Intervention
metformin hydrochloride
Why stopped
study was never opened to accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-02-20